Systemic Hypertension

The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension

Abstract

(Rus)

Valieva Z.S., Valeeva E.G., Glukhova S.I., Martynyuk T.V., Chazova I.E.

Vol 13, No 2 (2016)

Demographic and clinical differences between idiopathic and scleroderma-related pulmonary arterial hypertension: Russian National Registry analysis

Abstract

(Rus)

Yudkina N.N., Valeeva E.G., Taran I.N., Nikolaeva E.V., Paramonov V.M., Kurmukov I.A., Valieva Z.S., Arkhipova O.A., Martynyuk T.V., Volkov A.V., Nasonov E.L., Chazova I.E.

Vol 13, No 1 (2016)

The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Abstract

(Rus)

Valieva Z.S., Glukhova S.I., Martyniuk T.V., Chazova I.E.

Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data)

Abstract

(Rus)

Oshchepkova E.V., Lazareva N.V., Chazova I.E.

Vol 14, No 4 (2017)

Features of the use of torasemide in arterial hypertension

Abstract

(Rus)

Baryshnikova G.A., Chorbinskajya S.A.

Vol 16, No 4 (2019)

Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy

Abstract

(Rus)

Oshchepkova E.V., Avalyan A.A., Rogoza A.N., Gorieva S.B., Saidova M.A., Chazova I.E.

Possibilities of treatment of patients with resistant arterial hypertension

Abstract

(Rus)

Shugushev Z.K., Maximkin D.A., Ryumina A.S.

Vol 13, No 3 (2016)

The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan

Abstract

(Rus)

Zhernakova Y.V., Chazova I.E.

Vol 13, No 3 (2016)

Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology

Abstract

(Rus)

Dolgova E.V., Fedorovich A.A., Martynyuk T.V., Rogoza A.N., Chazova I.E.

Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension

Abstract

(Rus)

Arkhipova O.A., Gratsianskaya S.E., Martynyuk T.V.

Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment

Abstract

(Rus)

Arkhipova O.A., Martynyuk T.V.

Vol 14, No 4 (2017)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V

Abstract

(Rus)

Chazova I.Y., Tyulyandin S.A., Vitsenia M.V., Poltavskaya M.G., Gilyarov M.Y., Martynyuk T.V., Ovchinnikov A.G., Panchenko E.P., Fedotkina Y.A., Stenina M.B., Trophimova O.P., Ageev F.T.

Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system

Abstract

(Rus)

Mozheyko M.E., Eregin S.Y., Vigdorchik A.V., Klimovskaia I.M., Riahi F., Hughes D.

Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine

Abstract

(Rus)

Kuznetsova E.G., Glukhova S.I., Martynyuk T.V., Nakonechnikov S.N., Chazova I.E.

Vol 16, No 3 (2019)

Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice

Abstract

(Rus)

Gratsianskaya S.E., Valieva Z.S., Zorin A.V., Martynyuk T.V.

Myocardial ischemia in patients with pulmonary arterial hypertension

Abstract

(Rus)

Arkhipova O.A., Martyniuk T.V., Valeeva E.G., Ryabykina G.V., Samoylenko L.E., Sergienko V.B., Chazova I.E.

Vol 13, No 3 (2016)

Workplace hypertension": focus on emotional and personality traits in patients

Abstract

(Rus)

Ostroumova O.D., Pervichko E.I., Zinchenko Y.P.

Vol 13, No 2 (2016)

Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy

Abstract

(Rus)

Ostroumova O.D., Kochetkov A.I., Lopukhina M.V.

Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension

Abstract

(Rus)

Shchelkova G.V., Zairova A.R., Danilov N.M., Rogoza A.N., Chazova I.E.

The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea

Abstract

(Rus)

Elfimova E.M., Zairova A.R., Andrievskaya M.V., Bogieva R.M., Rogoza A.N., Litvin A.Y.

Vol 15, No 1 (2018)

Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2

Abstract

(Rus)

Statsenko M.E., Turkina S.V., Titarenko M.N.

Chronic myocardial damage in idiopathic pulmonary arterial hypertension: a clinical case

Abstract

(Rus)

Bykov A.N., Arkhipov M.V., Klimusheva N.F., Iofin A.I., Krokhalev V.Y.

Three calcium antagonists: a place of everyone in treatment arterial hypertension (ALTERNATIVE study)

Abstract

Chazova I.E., Ratova L.G.

Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion

Abstract

(Rus)

Litvin A.Y., Elfimova E.M., Chazova I.E.

«New» molecules composed of rational combinations of antihypertensive drugs: issues of choice

Abstract

(Rus)

Kislyak O.A., Chervyakova Y.B.

Vol 11, No 2 (2014)

National questionnaire of treatment compliance:testing and application in outpatient practice

Abstract

(Rus)

Fofanova T.V., Ageev F.T., Smirnova M.D., Svirida O.N., Kuzmina A.E., Thostov A.S., Nelyubina A.S.

Vol 9, No 4 (2012)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia

Abstract

Nedogoda S.V., Ledyaeva A.A., Chumachok E.V., Tsoma V.V., Salasyuk A.S.

Vol 16, No 4 (2019)

Target blood pressure levels in patients with arterial hypertension and frailty

Abstract

(Rus)

Ostroumova O.D., Cherniaeva M.S., Morozov A.P.

Vol 6, No 1 (2009)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan

Abstract

Baryshnikova G.A., Baryshnikova G.A.

Vol 15, No 1 (2018)

Pulmonary hypertension: reasonable selection of specific therapy

Abstract

(Rus)

Karoli N.A., Sazhnova S.I., Rebrov A.P.

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension

Abstract

(Rus)

Ageev F.T., Smirnova M.D., Fofanova T.V., Blankova Z.N., Vitsenya M.V., Tsybulskaya T.V., Neverova E.F., Samsonova N.S.

The meaning of hypertensive therapy choice in the correction of cerebral affection: from mild cognitive impairment to dementia

Abstract

(Rus)

Shishkova V.N.

Vol 10, No 4 (2013)

Rational pharmacotherapy of hypertension. Urapidil potential

Abstract

Morozova T.E., Andruschishina T.B., Shmarova D.G.

Vol 16, No 3 (2019)

Features of arterial hypertension patients with discrepancies in vectorcardiographic and echocardiographic conclusions about the presence of left ventricular hypertrophy [Original Article]

Abstract

(Rus)

Blinova E.V., Sakhnova T.A., Chaykovskaya O.Y., Saidova M.A., Ryabykina G.V.

Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy

Abstract

(Rus)

Avalyan A.A., Oshchepkova E.V., Saidova M.A., Shitov V.N., Glazkova E.V., Stenina M.B., Chazova I.E.

A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial

Abstract

(Rus)

Ostroumova O.D., Fomina V.M., Smolyarchuk E.A.

Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension

Abstract

(Rus)

Zavyrylina I.N., Arkhipova O.A., Saidova M.A., Danylov N.M., Martynyuk T.V., Chazova I.E.

Why occurrence of arterial hypertension with age becomes frequent?

Abstract

(Rus)

Poseliugina O.B., Poseliugina E.B., Al-Galban N.

Vol 10, No 1 (2013)

Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension

Abstract

Ostroumova O.D., Pervichko E.I.

Vol 6, No 3 (2009)

Dynamics of blood pressure, heart rate variability and QTc in patients with metabolic syndrome on the selective betablockerand biguanide therapy.

Abstract

Ryabykina G.V., Shishova T.A., Laptev D.N., Mychka V.B., Lyutikova L.N., Kozhemyakina E.S., Shchedrina E.V., Sobolev A.V., Chazova I.E.

Nitrogen oxide biochemical pathway in pulmonary arterial hypertension therapy and REPLACE trial results

Abstract

(Rus)

Shmalts A.A., Gorbachevsky S.V.

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application

Abstract

(Rus)

Maksimov M.L., Dralova O.V.

Vol 13, No 1 (2016)

The role of b-blockers in treatment of hypertension, according to Russian and European experts

Abstract

(Rus)

Ostroumova O.D., Fomina V.M., Shchukina G.N., Smoliarchuk E.A.

Heart rate in patients with arterial hypertension:a possible marker of high risk or independent therapeutic target?

Abstract

(Rus)

Kobalava Z.D., Shavarova E.K.

Vol 11, No 1 (2014)

New trends in the treatment of hypertension in 2013: the renaissance of pulse pressure

Abstract

(Rus)

Ostroumova O.D., Galeeva N.Y.

Vol 9, No 4 (2012)

Diuretics in arterial hypertension: a focus on torasemide

Abstract

Baryshnikova G.A., Stepanova I.I.

Vol 16, No 4 (2019)

Risk factors for falls in patients with arterial hypertension

Abstract

(Rus)

Khovasova N.O., Naumov A.V., Tkacheva O.N., Moroz V.I.

Vol 6, No 3 (2009)

Efficacy of the fixed combination β-blocker and calcium antagonist Logimax at women with an essential hypertensionin different age groups

Abstract

Ostroumova O.D., Zhukova O.V., Golovina O.V., Srednyakov A.V., Otdelenov A.V.

Vol 15, No 1 (2018)

The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies

Abstract

(Rus)

Klimova A.A., Ambatello L.G., Smolyakova E.V., Nistor S.Y., Zykov K.A., Chazova I.E.

Vol 12, No 3 (2015)

Fixed dose combinations for the treatment arterial hypertension: the real way to improve control

Abstract

(Rus)

Morozova T.E., Andreev S.S.

Effect of sildenafil on clinical evidence and hemodynamic parameters in patients with pulmonary arterial hypertension, associated withsystemic rheumaticdiseases

Abstract

(Rus)

Volkov A.V., Udkina N.N., Kurmukov I.A., Nikolaeva Y.A., Nasonov Y.L.

A modern phylogenetic theory of pathology, pathogenesis of essential arterial hypertension and universal algorhythm of damage to the target organs

Abstract

Titov V.N.

Vol 16, No 1 (2019)

Obesity and hypertension: the role of criteria

Abstract

(Rus)

Tsygankova D.P., Krivoshapova K.E., Maksimov S.A., Indukaeva E.V., Shapovalova E.B., Artamonova G.V., Barbarash O.L.

Clinical-pharmacological priorities in the election of blockators of the renin-angiotenzine system and diuretics in patients with uncompleted hypertension

Abstract

(Rus)

Ponomareva A.I., Ketova G.G., Kompaniets O.G.

Clinical effects of one-year physical training program in arterial hypertension patients of working age who have suffered acute myocardial infarction (Russian randomized controlled trial)

Abstract

(Rus)

Aronov D.M., Bubnova M.G., Krasnitskiy V.B., Ioseliani D.G., Grinshteyn Y.I., Gulyaeva S.F., Efremushkin G.G., Lyamina N.P.

Calcium channel blockers: more than 50 years on guard of health

Abstract

(Rus)

Chazova I.E., Zhernakova Y.V.

The impact of fixed combination of amlodipine and perindopril (drug Prestance)on the mechanisms of heat adaptation in patients with arterial hypertension

Abstract

(Rus)

Ageev F.T., Smirnova M.D., Fofanova T.V., Svirida O.N., Mikhailov G.D., Revich B.A.

Torasemide: additional benefits for postmenopausal women with arterial hypertension

Abstract

Tkacheva O.N., Runikhina N.K., Sharashkina N.V.

Amlodipine: its ability to reduce the risk of complications of arterial hypertension

Abstract

Runikhina N.K., Tkacheva O.N.

Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients

Abstract

(Rus)

Zhernakova Y.V., Martyniuk T.V., Arkhipova O.A., Azimova M.O., Rogoza A.N., Chazova I.E.

From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift

Abstract

(Rus)

Ostroumova O.D., Bondarets O.V., Kopchenov I.I., Guseva T.F.

The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects

Abstract

(Rus)

Gilyarevsky S.R.

Vol 11, No 1 (2014)

Place of arterial hypertension in brain lesion development - from minor cognitive disorders to dementia

Abstract

(Rus)

Shishkova V.N.

Vol 9, No 4 (2012)

Diurnal blood pressure variability as a risk factor for complications of arterial hypertension

Abstract

Ostroumova O.D., Reznikova K.U.

Vol 6, No 1 (2009)

Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin

Abstract

Ezhov M.V., Yezhov M.V.

Vol 14, No 3 (2017)

Calcineurin inhibitors and arterial hypertension in recipients of solid organs

Abstract

(Rus)

Kosmacheva E.D., Martirosyan S.M., Lepshokova M.K., Babich A.E.

Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach

Abstract

(Rus)

Zhernakova Y.V., Sharipova G.H., Chazova I.E.

Phylogentic theory of pathology. Common phylogenetic features in the pathogenesis of essential arterial hyperntesion and insulin resistance syndrome

Abstract

(Rus)

Titov V.N.

Vol 10, No 4 (2013)

Place of angiotensin receptor blockers in the treatment of hypertension according to the latest recommendations of the 2013 European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) for the treatment of hypertension

Abstract

Chukaeva I.I., Solovieva M.V., Litvinova S.N.

Candesartan in the prevention of cardiovascular catastrophes: emphasis on the pre-vention of stroke

Abstract

Drapkina O.M., Dikur O.N.

Organoprotection with arterial hypertension 2-3 degrees

Abstract

(Rus)

Afonicheva I.I., Melnik M.V., Knyazeva S.A., Kazyulin A.A.

The hardness of the vessel wall in patients with arterial hypertension

Abstract

(Rus)

Ostroumova O.D., Kochetkov A.I., Kopchenov I.I., Guseva T.F., Bondarec O.V.

Vol 11, No 2 (2014)

Chronic obstructive pulmonary disease combined with arterial hypertension: efficacy and safety ofthesustained-release indapamide (Arifon® retard)

Abstract

(Rus)

Ovcharenko S.I., Nersesyan Z.N., Morozova T.E.

Combined pharmacotherapy for arterial hypertension: a view through the 2013 clinical practice guidelines

Abstract

Rodionov A.V.

Vol 6, No 1 (2009)

Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome

Abstract

Mychka V.B., Chazova I.E., Mychka V.B., Chazova I.E.

Vol 15, No 3 (2018)

Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]

Abstract

(Rus)

Chazova I.E., Zhernakova Y.V.

The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension

Abstract

(Rus)

Elfimova E.M., Rvacheva A.V., Tripoten M.I., Pogorelova O.V., Balakhonova T.V., Zykov K.A., Litvin A.Y.

Treatment with perindopril in patients with arterial hypertension: improving compliance

Abstract

(Rus)

Anikin G.S., Minina E.S., Andreevskaya E.M.

The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders

Abstract

(Rus)

Zhernakov Y.V., Chazova I.Y.

Vol 11, No 1 (2014)

Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components

Abstract

(Rus)

Zhernakova Y.V., Sharipova G.K., Chazova I.E.

Vol 6, No 2 (2009)

HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association

Abstract

Vol 16, No 3 (2019)

The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus

Abstract

(Rus)

Zhernakova J.V., Chazova I.E., Blinova N.V.

Vol 6, No 3 (2009)

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.

Abstract

Ratova L.G., Chazova I.E.

Vol 14, No 3 (2017)

The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations

Abstract

(Rus)

Ostroumova O.D., Piksina G.F., Smolyarchuk E.A., Pavleeva E.E., Bondarets O.V.

Radiofrequency renal arteries denervation: effectively and safely

Abstract

Grigin V.A., Danilov N.M., Matchin Y.G., Chazova I.E.

Medical and social risk factors for arterial hypertension in coal miners

Abstract

(Rus)

Indukaeva E.V., Makarov S.A., Ogarkov M.Y.

Legochnaya arterial'naya gipertenziya: na puti ot ratsional'noy diagnostiki k vyboru effektivnoy lekarstvennoy terapii

Abstract

Chazova I.E., Martynyuk T.V.

Arterial hypertension in the elderly and higher mental functions. Possibilities of an-tihypertensive therapy withArifon retard in the prevention of dementia.

Abstract

Ostroumova O.D., Korsakova N.K., Varako N.A.

Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes

Abstract

(Rus)

Kovalenko F.A., Skibitsky V.V., Fendrikova A.V.

A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment

Abstract

(Rus)

Temnikova E.A.

Once again about the clinical efficacy and safety of sartans

Abstract

(Rus)

Minina Y.S., Khadzhieva B.R.

Psychosomatic Aspects of Low Adherence to Antihypertensive Therapy in Patients with Arterial Hypertension

Abstract

(Rus)

Fofanova T.V., Ageyev F.T., Kadushina E.B., Drobizhev M.Y., Smirnova M.D., Kuzmina A.E.

Vol 10, No 1 (2013)

Antihypertensive efficacy of a fixed full-dose perindopril A-indapamide combination in patients with grades 2–3 arterial hypertension

Abstract

Glukhova T.V., Solgalova S.A., Alferov V.V.

The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension

Abstract

Zagidullin N.S., Zagidullin S.Z.

Stroke prevention in patients with atrial fibrillation and comorbidities

Abstract

(Rus)

Ostroumova O.D., Voevodina N.Y., Guseva T.F., Pavleeva E.E., Piksina G.F., Goloborodova I.V.

Treatment of patients with high cardiovascular risk: a modern view on combined therapy

Abstract

(Rus)

Blankova Z.N., Aslanian N.S., Smolianinova N.G., Ageev F.T.